FSVP by Product · Dietary Supplements
Imported Dietary Supplement Classification: FSVP Scope and Disease Claims
Importers of dietary supplements often jump straight to supplier documents. However, imported dietary supplement classification should come first. What the article is, and how it is marketed, decides which FDA rules apply. Only then can you choose the right Foreign Supplier Verification Program (FSVP) pathway and assign duties.
The FSVP rule in 21 CFR Part 1, Subpart L does not treat every supplement shipment the same way. It includes modified requirements for dietary supplements and their components. Meanwhile, claims on labels, websites and listings can change whether FDA regulates the product as a drug. This guide shows how to keep those questions in the right order.
- ArticleFinished supplement, component or other food.
- Intended useScreen claims that point to a drug.
- PathwayStandard FSVP or a 1.511 pathway.
- RolesImporter, supplier and record holders.
- ReassessRecheck when claims or suppliers change.
Classification first, then the FSVP pathway, then ongoing reassessment.
1. Confirm the imported article and its category
Start by naming exactly what crosses the border. Is it a finished dietary supplement, a dietary ingredient for further manufacturing, a conventional food, or something else? Each answer leads to different obligations.
Next, look at intended use. Under the Federal Food, Drug, and Cosmetic Act, articles intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease are drugs (21 U.S.C. 321(g)(1)). As a result, the words “dietary supplement” on a label do not settle the question on their own.
2. Screen claims that could make the product a drug
FDA’s rule on structure/function statements explains when a statement becomes a disease claim (21 CFR 101.93(g)). For example, a claim that a product affects a specific disease, or its characteristic signs or symptoms, is a disease claim. The rule also says FDA considers the context in which a claim is presented, including product names, pictures and cited publications.
If the labeling of a product marketed as a dietary supplement bears a disease claim, the product is subject to regulation as a drug, unless the claim is an authorized health claim for which the product qualifies. Therefore, review existing claims on labels, storefronts and promotional materials before you finalize the import pathway. Escalate any disease-related wording to a regulatory reviewer.
3. Evaluate the FSVP pathway and document the basis
For a product that remains a dietary supplement or component, decide which FSVP requirements apply. The modified requirements in 21 CFR 1.511 set out three situations:
- 1.511(a): you establish specifications under 21 CFR 111.70(b) or (d) for a supplement or component you import for further manufacturing, and you comply with 111.73 and 111.75. You must then meet 1.503 and 1.509.
- 1.511(b): your customer establishes those specifications and complies with 111.73 and 111.75, and you obtain its written assurance annually. You must then meet 1.503, 1.509 and 1.510.
- 1.511(c): you import a finished dietary supplement and neither (a) nor (b) applies. You follow modified supplier evaluation, approval and verification requirements.
Other foods follow the standard FSVP requirements unless an exemption in 21 CFR 1.501 applies. In each case, write down the facts behind your decision rather than assuming all supplement imports are treated alike. Our guide to dietary supplement components and FSVP covers the 1.511 pathways in more depth.
What a classification file usually records
- The exact imported article, its form and its intended further processing.
- Current label, website and listing claims reviewed for intended use.
- The FSVP pathway chosen (standard, 1.511(a), (b) or (c), or an exemption) and why.
- The FSVP importer, foreign manufacturer and supplier for each product.
- Who keeps each required record and where it is stored.
- Dates and triggers for the next reassessment.
4. Keep supplier verification separate from claims review
Supplier qualifications and manufacturing evidence matter for FSVP. Even so, they answer a different question from therapeutic claims. An audit report or supplier approval does not make a disease claim acceptable. Handle intended use through its own review, with its own reviewer and records. For a closer look at that split, see why supplier verification is not claims review.
5. Identify importer and supplier responsibilities
Document the FSVP importer: generally the U.S. owner or consignee at the time of entry, or, if there is none, the U.S. agent or representative named in a signed statement of consent (21 CFR 1.500). In addition, record the foreign supplier, the product specification and the manufacturing arrangement. Finally, note who maintains each required record.
6. Maintain records and reassess changes
Classification is not a one-time decision. A new formulation, a new supplier or a new promotional claim can change the answer. Track supplier documentation, product changes and new claims together, so one change triggers a review of the others. Where 1.510 applies, FSVP records must generally be kept for at least two years after they are created or obtained.
Imported dietary supplement classification checklist
- Determine the exact imported article and its FDA regulatory category.
- Screen labels, webpages and listings for disease claims that suggest drug use.
- Document standard FSVP, the 1.511 pathway or the exemption you rely on.
- Identify the importer, manufacturer, supplier and record custodians.
- Keep claims review separate from supplier verification.
- Reassess when formulations, promotional use or supplier arrangements change.
Frequently asked questions
Are all imported dietary supplements subject to the same FSVP activities?
No. 21 CFR 1.511 sets modified requirements that depend on who establishes Part 111 specifications and whether the product is a finished supplement or a component. Other foods follow the standard FSVP requirements unless an exemption applies.
Can FSVP compliance authorize disease-treatment claims?
No. FSVP addresses supplier verification for imported food. Whether a claim makes a product a drug is a separate question under FDA’s intended-use and labeling rules.
Could a marketing change affect the import review?
Yes. A claim that changes intended use can change the product’s classification, and therefore the requirements you need to assess.
How Consultare Inc. Group can help
Consultare supports FSVP applicability assessments, importer-role clarification, supplier evaluations where applicable, documentation review and verification planning. Claims questions can be scoped separately through website content regulatory review and product label review. Deliverables depend on the product, the operation and the agreed engagement.
Related services
- FSVP compliance readiness and gap assessment
- Product label regulatory review
- Regulatory compliance technical advisory
- FSVP for dietary supplements
- Dietary supplement testimonials and FSVP records
- Imported supplement website claims
Need help meeting your FSVP responsibilities as a food importer?
Discuss your imported foods, foreign suppliers, importer arrangements and existing verification records with the Consultare team. Request a free consultation to identify potential gaps and plan the next steps.
Request a Free ConsultationBook a ConsultationStart building your compliance system
Prefer to manage compliance yourself? Create a free SystemsBuilder account to organize product and supplier information, approved documents, review decisions and corrective action records. Software supports record organization; it does not replace qualified regulatory review.
Primary references
- 21 CFR 1.511: FSVP for foods subject to dietary supplement CGMP requirements
- 21 CFR 1.501: Foods subject to FSVP and exemptions
- 21 CFR 1.500: FSVP definitions, including importer
- 21 CFR 101.93: Structure/function statements and disease claims
- 21 U.S.C. 321: Definitions, including drug
- FDA: FSVP Rule at a Glance
Independent educational content. Consultare Inc. Group is not affiliated with or endorsed by the U.S. Food and Drug Administration (FDA). This article is not legal advice and does not constitute regulatory approval or certification; regulatory applicability must be assessed for each product, importer and operation.

